Diversified Trust Co Has $92,000 Holdings in Quorum Health Corp (NYSE:QHC)

Share on StockTwits

Diversified Trust Co grew its stake in Quorum Health Corp (NYSE:QHC) by 582.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 76,168 shares of the company’s stock after buying an additional 65,000 shares during the quarter. Diversified Trust Co owned 0.23% of Quorum Health worth $92,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Paloma Partners Management Co boosted its holdings in shares of Quorum Health by 57.4% in the second quarter. Paloma Partners Management Co now owns 134,500 shares of the company’s stock valued at $187,000 after buying an additional 49,026 shares during the period. KBC Group NV acquired a new position in shares of Quorum Health in the second quarter valued at approximately $36,000. Vanguard Group Inc. boosted its holdings in shares of Quorum Health by 20.0% in the second quarter. Vanguard Group Inc. now owns 1,864,993 shares of the company’s stock valued at $2,592,000 after buying an additional 310,554 shares during the period. Jane Street Group LLC boosted its holdings in shares of Quorum Health by 337.8% in the second quarter. Jane Street Group LLC now owns 81,858 shares of the company’s stock valued at $114,000 after buying an additional 63,159 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in shares of Quorum Health by 220.2% in the second quarter. Renaissance Technologies LLC now owns 542,288 shares of the company’s stock valued at $754,000 after buying an additional 372,909 shares during the period. Institutional investors own 74.97% of the company’s stock.

QHC has been the subject of several research analyst reports. ValuEngine upgraded shares of Quorum Health from a “hold” rating to a “buy” rating in a report on Wednesday, October 2nd. Royal Bank of Canada reiterated a “hold” rating and issued a $2.00 price target on shares of Quorum Health in a report on Sunday, August 11th.

Quorum Health stock opened at $1.28 on Friday. The stock has a market capitalization of $37.85 million, a PE ratio of -0.78 and a beta of 2.01. Quorum Health Corp has a twelve month low of $0.91 and a twelve month high of $5.74. The company has a 50 day moving average of $1.22 and a 200-day moving average of $1.48.

Quorum Health (NYSE:QHC) last announced its earnings results on Wednesday, August 7th. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.02). The company had revenue of $442.17 million for the quarter, compared to analyst estimates of $475.01 million. During the same period last year, the firm earned ($0.33) EPS. The company’s revenue was down 6.4% compared to the same quarter last year.

Quorum Health Profile

Quorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, diagnostic, obstetric, psychiatric, and rehabilitation services.

See Also: What Are Treasury Bonds?

Want to see what other hedge funds are holding QHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quorum Health Corp (NYSE:QHC).

Institutional Ownership by Quarter for Quorum Health (NYSE:QHC)

Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MEI Pharma  Rating Lowered to Sell at Zacks Investment Research
MEI Pharma Rating Lowered to Sell at Zacks Investment Research
Portman Ridge Finance  Upgraded at ValuEngine
Portman Ridge Finance Upgraded at ValuEngine
Maxar Technologies  Upgraded at Zacks Investment Research
Maxar Technologies Upgraded at Zacks Investment Research
DHI Group Inc  Short Interest Update
DHI Group Inc Short Interest Update
Customers Bancorp Inc  Sees Significant Decline in Short Interest
Customers Bancorp Inc Sees Significant Decline in Short Interest
CoTrader   Trading 19.5% Lower  Over Last 7 Days
CoTrader Trading 19.5% Lower Over Last 7 Days


© 2006-2019 Ticker Report